Full-Time

Material Handler I; Non-Union Warehouse

Posted on 3/27/2026

Curia

Curia

1,001-5,000 employees

End-to-end drug development and manufacturing

No salary listed

No H1B Sponsorship

Albuquerque, NM, USA

In Person

On-site warehouse role located in Albuquerque, NM; no remote option indicated; no hybrid requirement mentioned.

Category
Data & Analytics (1)
Required Skills
Inventory Management
Requirements
  • High-school education or equivalent
  • Minimum 1 years’ experience in material management, including inventory control responsibilities
  • ERP experience
  • Must perform accurate ERP transactions
  • Ensure cGMP training is up to date and complete
  • Adhere to SOPs, Human Resource policies, Department Guidelines, OSHA/Safety practices, GAAP and cGMP
Responsibilities
  • Pull, pick up, and deliver/transport materials for manufacturing operations to and from Building 4401 to Building 4272
  • Pickup WIP completed lots from building 4272 and store in building 4401
  • Monitor Kanban area of Bldg. 4272 to ensure optimum replenishment of materials and fax reorder to vendor or planner
  • Perform inventory transfers, work order issues, returns, and other related transactions using DSI scanners
  • Deliver materials determined by Parts List for Production such as stoppers, vials, seals, filters, and glass and transport materials to Bldg. 4272
  • Prepare and deliver raw materials, samples, finished product, etc. to various departments as needed ensuring proper procedure and temperature range are followed
  • Perform A-bin audits weekly including movement of released material from quarantine area to A-B bins
  • Maintain accurate inventory
  • Assist in performing inventory cycle counts
  • Receive incoming materials: perform Ross transactions, overhead stocking and chemical conversion to appropriate unit of measurement
  • Cross-train in all functional areas of the Warehouse and PEM operations
  • Provide support to all functional areas in Warehouse and PEM operations as needed
  • Support shipping, receiving, materials handling, deliveries, and transportation as required
  • Ensure cGMP training is up to date and complete
  • Ensure assignees adhere to ALL SOPs, Human Resource policies, Department Guidelines, OSHA/Safety practices, GAAP and cGMP
  • Performs accurate ERP transactions
  • Other duties as assigned
Desired Qualifications
  • ERP experience
  • Minimum 1 years’ experience in material management, including inventory control responsibilities

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$1.1B

Headquarters

Albany, New York

Founded

1991

Simplify Jobs

Simplify's Take

What believers are saying

  • Biologics segment expansion under Steve Lavezoli accelerates high-margin pharmaceutical outsourcing revenue growth.
  • Carterra partnership positions Curia to capture Pacific Northwest biotech demand in antibody discovery services.
  • Gerald Auer's CFO appointment signals M&A activity and potential strategic initiatives enhancing shareholder value.

What critics are saying

  • Pace Life Sciences acquisition of New Jersey lab erodes Curia's analytical testing capacity and revenue.
  • Larger CDMOs like Lonza and Catalent undercut Curia on biologics capacity, stealing biotech contracts.
  • FDA scrutiny on srRNA manufacturing defects from Replicate Bioscience Phase 1 triggers potential client exodus.

What makes Curia unique

  • Pioneer in self-replicating RNA manufacturing, demonstrated through Replicate Bioscience Phase 1 clinical trial support.
  • Integrated enzymatic doggybone DNA technology via Touchlight collaboration expands mRNA manufacturing competitive advantages.
  • End-to-end CDMO services from discovery through cGMP manufacturing differentiate Curia from specialized competitors.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
The Carlyle Group
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb.com
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

PPI News Agency
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.

INACTIVE